Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-01 Sale | 2024-02-02 9:25 pm | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 11,819 | $3.843 | $45,420 | 303,489 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-01-31 Exercise | 2026-02-03 7:47 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 84,166 | $0 | 284,622 (Direct) | View |
| 2026-01-31 Option Award | 2026-02-03 7:47 pm | N/A 2036-01-30 | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 119,520 | $0 | 284,622 (Direct) | View |
| 2026-01-31 Tax Withholding | 2026-02-03 7:47 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 11,570 | $4.24 | 284,622 (Direct) | View |
| 2025-01-31 Exercise | 2025-02-04 6:00 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 33,333 | $0 | 309,472 (Direct) | View |
| 2025-01-31 Option Award | 2025-02-04 6:00 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 141,550 | $0 | 309,472 (Direct) | View |
| 2025-01-31 Tax Withholding | 2025-02-04 6:00 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 11,517 | $3.06 | 309,472 (Direct) | View |
| 2024-01-31 Exercise | 2024-02-02 9:25 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 33,334 | $0 | 303,489 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 9:25 pm | N/A 2034-01-30 | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 132,800 | $0 | 303,489 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 6:26 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 240,000 | $0 | 240,000 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 5:15 pm | N/A 2032-01-30 | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 135,000 | $0 | 135,000 (Direct) | View |